Etanercept for steroid-refractory acute graft versus host disease following allogeneic hematopoietic stem cell transplantation
Joo Han Park, Hyo Jung Lee, Sei Rhan Kim, Ga Won Song, Seung Kyong Lee, Sun Young Park, Ki Chan Kim, Sun Hyuk Hwang, Joon Seong Park
Korean J Intern Med. 2014;29(5):630-636.   Published online 2014 Aug 28     DOI: https://doi.org/10.3904/kjim.2014.29.5.630
Citations to this article as recorded by Crossref logo
Etanercept as Treatment of Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric Patients
Maura Faraci, Maria Grazia Calevo, Stefano Giardino, Massimiliano Leoni, Erica Ricci, Elio Castagnola, Edoardo Lanino
Biology of Blood and Marrow Transplantation.2019; 25(4): 743.     CrossRef
Safety and Effectiveness of Vedolizumab in Patients with Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease: A Retrospective Record Review
Yngvar Fløisand, Vladimir Lj Lazarevic, Johan Maertens, Jonas Mattsson, Nirav N. Shah, Pierre Zachée, Aliki Taylor, Mona Akbari, Syed Quadri, Andrejus Parfionovas, Yi-Bin Chen
Biology of Blood and Marrow Transplantation.2019; 25(4): 720.     CrossRef
Tumor Necrosis Factor α and Regulatory T Cells in Oncoimmunology
Benoît L. Salomon, Mathieu Leclerc, Jimena Tosello, Emilie Ronin, Eliane Piaggio, José L. Cohen
Frontiers in Immunology.2018;[Epub]     CrossRef
Advance in Targeted Immunotherapy for Graft-Versus-Host Disease
Lingling Zhang, Jianhua Yu, Wei Wei
Frontiers in Immunology.2018;[Epub]     CrossRef
Poor prognosis in patients with steroid refractory acute graft versus host disease treated with etanercept: a multi-centre analysis
Chun Kei Kris Ma, Irene García-Cadenas, María Laura Fox, Sylvia Ai, Ian Nivison-Smith, Samuel Thomas Milliken, Anthony Dodds, Keith Fay, David D. F. Ma, Rodrigo Martino, Jorge Sierra, John Moore
Bone Marrow Transplantation.2018; 53(11): 1478.     CrossRef
Off-Label uses of Biologic Agents Approved for Psoriasis and Psoriatic Arthritis for Dermatological Conditions: Part II
Amira Elbendary, Roselyn Kellen
Journal of Psoriasis and Psoriatic Arthritis.2017; 2(2): 65.     CrossRef
Insurance approval of mesenchymal stem cell for acute GVHD in Japan: need of follow up for some remaining concerns
Koichi Miyamura
International Journal of Hematology.2016; 103(2): 155.     CrossRef
Therapeutic targets and emerging treatment options in gastrointestinal acute graft-versus-host disease
Anne S. Renteria, John E. Levine, James L. M. Ferrara
Expert Opinion on Orphan Drugs.2016; 4(5): 469.     CrossRef
Extracorporeal photopheresis and anticytokine therapy in the treatment of steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation in children
Andrey V Kozlov, Julia G Fedukova, Tatzana A Bykova, Ivan S Moiseev, Marya A Estrina, Irina I Kulagina, Sergey N Bondarenko, Elena V Morozova, Anna A Osipova, Anastasya S Borovkova, Svetlana V Razumova, Ludmila S Zubarovskaya, Boris V Afanasyev
Pediatrician (St. Petersburg).2016; 7(1): 58.     CrossRef
Ruxolitinib in steroid refractory graft-vs.-host disease: a case report
Enrico Maffini, Luisa Giaccone, Moreno Festuccia, Lucia Brunello, Ilaria Buondonno, Dario Ferrero, Mario Boccadoro, Chiara Dellacasa, Alessandro Busca, Domenico Novero, Benedetto Bruno
Journal of Hematology & Oncology.2016;[Epub]     CrossRef
Graft Versus Host Disease After Liver Transplantation in Adults
Arvind R. Murali, Subhash Chandra, Zoe Stewart, Bruce R. Blazar, Umar Farooq, M. Nedim Ince, Jeffrey Dunkelberg
Transplantation.2016; 100(12): 2661.     CrossRef